STOCK TITAN

HealthEquity founder disposes of 1,095 shares

The founder and vice chairman also reported three directly held option positions, each immediately exercisable and expiring between March 27, 2027, and March 26, 2029.

(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

HealthEquity, Inc. (HQY) reported that founder and vice chairman Stephen Neeleman had 1,095 shares delivered or withheld for payment of exercise price or tax liability on October 6, 2026. The transaction lists a per-share price of $91.1553; his direct common-stock holdings after the transaction were 136,470 shares. He also reported three immediately exercisable stock-option positions: 19,897 underlying shares at a $41.28 exercise price, expiring March 27, 2027; 14,228 underlying shares at $61.72, expiring March 27, 2028; and 15,337 underlying shares at $73.61, expiring March 26, 2029.

Insider Neeleman Stephen
Role FOUNDER AND VICE CHAIRMAN
Type Security Shares Price Value
Exercise Price or Tax Liability Common Stock 1,095 $91.1553 $100K
holding Stock Option (right to buy) F4 -- -- --
holding Stock Options (right to buy) F4 -- -- --
holding Stock Options (right to buy) F4 -- -- --
holding Common Stock F1 -- -- --
holding Common Stock F2 -- -- --
holding Common Stock F3 -- -- --
Holdings After Transaction: Common Stock — 136,470 shares (Direct); Stock Option (right to buy) — 19,897 contracts (Direct); Stock Options (right to buy) — 29,565 contracts (Direct); Common Stock — 751,235 shares (Indirect, See footnote)
Footnotes (4)
  1. F1. Shares held of record by the Stephen and Christine Neeleman Trust.
  2. F2. The securities are beneficially owned by the Reporting Person's spouse. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
  3. F3. Shares held of record by Neeleman Family Holdings, LLC ("Family Holdings"), a Utah limited liability company. The reporting person is the manager of Family Holdings. The reporting person disclaims beneficial ownership of the shares held by Family Holdings except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the shares held by Family Holdings for any other purposes.
  4. F4. The option is immediately exercisable.
Shares delivered or withheld 1,095 shares October 6, 2026; for payment of exercise price or tax liability
Reported per-share price $91.1553 per share October 6, 2026 transaction
Direct common-stock holdings after transaction 136,470 shares After the October 6, 2026 transaction
Option position expiring March 27, 2027 19,897 underlying shares; $41.28 exercise price Immediately exercisable
Option position expiring March 27, 2028 14,228 underlying shares; $61.72 exercise price Immediately exercisable
Option position expiring March 26, 2029 15,337 underlying shares; $73.61 exercise price Immediately exercisable
exercise price or tax liability financial
"Payment of exercise price or tax liability by delivering or withholding securities"
immediately exercisable technical
"The option is immediately exercisable."
beneficial ownership financial
"The reporting person disclaims beneficial ownership of these securities"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
pecuniary interest financial
"except to the extent of his pecuniary interest therein"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many HealthEquity (HQY) shares did Stephen Neeleman deliver or withhold?

Stephen Neeleman had 1,095 shares delivered or withheld for payment of exercise price or tax liability on October 6, 2026. The transaction lists a per-share price of $91.1553, and his direct common-stock holdings afterward were 136,470 shares.

What stock options did Stephen Neeleman report for HealthEquity (HQY)?

He reported three immediately exercisable option positions: 19,897 underlying shares at a $41.28 exercise price, expiring March 27, 2027; 14,228 shares at $61.72, expiring March 27, 2028; and 15,337 shares at $73.61, expiring March 26, 2029.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Neeleman Stephen

(Last)(First)(Middle)
C/O HEALTHEQUITY, INC.
15 W. SCENIC POINTE DR., STE. 100

(Street)
DRAPER UTAH 84020

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
HEALTHEQUITY, INC. [ HQY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
FOUNDER AND VICE CHAIRMAN
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
10/06/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock10/06/2026F1,095D$91.1553136,470D
Common Stock408,235ISee footnote(1)
Common Stock140,000ISee footnote(2)
Common Stock203,000ISee footnote(3)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy)$41.28 (4)03/27/2027Common Stock19,89719,897D
Stock Options (right to buy)$61.72 (4)03/27/2028Common Stock14,22814,228D
Stock Options (right to buy)$73.61 (4)03/26/2029Common Stock15,33715,337D
Explanation of Responses:
1. Shares held of record by the Stephen and Christine Neeleman Trust.
2. The securities are beneficially owned by the Reporting Person's spouse. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
3. Shares held of record by Neeleman Family Holdings, LLC ("Family Holdings"), a Utah limited liability company. The reporting person is the manager of Family Holdings. The reporting person disclaims beneficial ownership of the shares held by Family Holdings except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the shares held by Family Holdings for any other purposes.
4. The option is immediately exercisable.
/s/ Stephen Neeleman10/08/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading